Lancet Oncology

The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content.

Publisher
Elsevier
Website
http://www.thelancet.com/journals/lanonc/issue/current
Impact factor
33.9 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

UK cancer treatment falls behind other countries, research finds

People in the UK have been treated with chemotherapy and radiotherapy less often than patients in comparable countries, and faced long waits for treatments, according to two new studies published in The Lancet Oncology.

Oncology & Cancer

Combination treatment improves lung cancer outcomes, finds study

A new study has found that patients with non-small cell lung cancer (NSCLC) treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy ...

page 1 from 38